Stock Scorecard
Stock Summary for Anika Therapeutics Inc (ANIK) - $26.49 as of 5/2/2024 6:20:42 PM EST
Total Score
10 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ANIK
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ANIK
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ANIK
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for ANIK
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for ANIK
Financial Details for ANIK
Company Overview |
|
---|---|
Ticker | ANIK |
Company Name | Anika Therapeutics Inc |
Country | USA |
Description | Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 6/13/2024 |
Stock Price History |
|
Last Day Price | 26.49 |
Last Day Price Updated | 5/2/2024 6:20:42 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 60,238 |
52-Week High | 28.12 |
52-Week Low | 16.54 |
Last Price to 52 Week Low | 60.16% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 48.15 |
Sector PE | 54.22 |
5-Year Average PE | 3.08 |
Free Cash Flow Ratio | 3.61 |
Industry Free Cash Flow Ratio | 63.59 |
Sector Free Cash Flow Ratio | 32.33 |
Current Ratio Most Recent Quarter | 5.26 |
Total Cash Per Share | 7.34 |
Book Value Per Share Most Recent Quarter | 14.48 |
Price to Book Ratio | 1.75 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.23 |
Price to Sales Ratio Twelve Trailing Months | 2.23 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.15 |
Share Statistics |
|
Total Shares Outstanding | 14,828,500 |
Market Capitalization | 392,806,965 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 15.60% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -50.50% |
Annual Earnings Growth | -456.34% |
Reported EPS 12 Trailing Months | -5.64 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -5.41 |
Net Income Twelve Trailing Months | -82,667,000 |
Net Income Past Year | -82,667,000 |
Net Income Prior Year | -14,859,000 |
Quarterly Revenue Growth YOY | 8.50% |
5-Year Revenue Growth | 9.44% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 108,828,000 |
Total Cash Past Year | 108,828,000 |
Total Cash Prior Year | 120,954,000 |
Net Cash Position Most Recent Quarter | 108,828,000 |
Net Cash Position Past Year | 108,828,000 |
Long Term Debt Past Year | 0 |
Long Term Debt Prior Year | 0 |
Total Debt Most Recent Quarter | 0 |
Equity to Debt Ratio Past Year | 1.00 |
Equity to Debt Ratio Most Recent Quarter | 1.00 |
Total Stockholder Equity Past Year | 212,265,000 |
Total Stockholder Equity Prior Year | 285,563,000 |
Total Stockholder Equity Most Recent Quarter | 212,265,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.10 |
MACD Signal | 0.13 |
20-Day Bollinger Lower Band | 21.81 |
20-Day Bollinger Middle Band | 24.46 |
20-Day Bollinger Upper Band | 27.10 |
Beta | 0.75 |
RSI | 50.43 |
50-Day SMA | 22.86 |
200-Day SMA | 30.77 |
System |
|
Modified | 5/2/2024 5:31:58 PM EST |